HomeNewsBusinessMarketsLast 10-year data suggests April belongs to bulls; will 2020 be different?

Last 10-year data suggests April belongs to bulls; will 2020 be different?

Nifty50 jumped over 6 percent in April 2018, followed by 4.3 percent in April 2013 and over 1.48 percent in April 2016 — three of the biggest gains in April in the last 10 years.

April 03, 2020 / 10:42 IST
Story continues below Advertisement

March turned out to be an absolute disaster for the D-Street. The benchmark indices Sensex and Nifty50 dropped about 23 percent each and slipped into bear territory.

Now, as we step into April, investors are hopeful that the worst is behind us. But, given the continued exponential rise in COVID-19 cases in India and across the world, recovery may still be some time away despite a slew of measures undertaken by the central bankers around the globe.

Story continues below Advertisement

Data from the last 10 years suggest that bulls got an upper hand seven times in the month of April.

Nifty50 jumped over 6 percent in April 2018, followed by 4.3 percent in April 2013 and over 1.48 percent in April 2016 — three of the biggest gains in April in the last 10 years.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show